Le Lézard
Classified in: Science and technology, Business
Subjects: MAV, ERN, CCA

Enghouse Q4 2020 Earnings Release and Conference Call


MARKHAM, ON, Dec. 14, 2020 /CNW/ - Enghouse Systems Limited (TSX: ENGH) announced today that it intends to release its fourth quarter Fiscal 2020 results after market close on Thursday, December 17, 2020.

A conference call to discuss these results will be held:


Friday, December 18, 2020 at 8:45 a.m. EST

The conference call can be accessed by dialing the following numbers:


Local/ International:

1-647-792-1278


North American Toll- Free: 

1-888-504-7961





Confirmation Code: 

3963967

This call will also be web-cast and can be accessed at the following web location:

https://onlinexperiences.com/Launch/QReg/ShowUUID=B4EF601C-3F2B-4AD0-A9E9-D8B057EE46E3

The call will be archived for one week and will be available at this same web location following the call or by visiting the Enghouse website at www.enghouse.com.

SOURCE Enghouse Systems Limited


These press releases may also interest you

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

26 avr 2024
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

26 avr 2024
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...



News published on and distributed by: